Authors: ATTANOOS RL PAPAGIANNIS A SUTTINONT P GODDARD H PAPOTTI M GIBBS AR

Citation: Rl. Attanoos et al., PULMONARY GIANT-CELL CARCINOMA - PATHOLOGICAL ENTITY OR MORPHOLOGICALPHENOTYPE, Histopathology, 32(3), 1998, pp. 225-231

Authors: ATTANOOS RL GODDARD H GIBBS AR

Citation: Rl. Attanoos et al., MESOTHELIOMA-BINDING ANTIBODIES - THROMBOMODULIN, OV-632 AND HBME-1 AND THEIR USE IN THE DIAGNOSIS OF MALIGNANT MESOTHELIOMA, Histopathology, 29(3), 1996, pp. 209-215

Authors: ATTANOOS RL GODDARD H THOMAS ND JASANI B GIBBS AR

Citation: Rl. Attanoos et al., A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY OF MALIGNANT MESOTHELIOMA ANDRENAL-CELL CARCINOMA - THE DIAGNOSTIC UTILITY OF LEU-M1, BER EP4, TAMM-HORSFALL PROTEIN AND THROMBOMODULIN, Histopathology, 27(4), 1995, pp. 361-366

Authors: MAYALL F RUTTY K CAMPBELL F GODDARD H

Citation: F. Mayall et al., P53 IMMUNOSTAINING SUGGESTS THAT UTERINE CARCINOSARCOMAS ARE MONOCLONAL, Histopathology, 24(3), 1994, pp. 211-214

Authors: MAYALL FG GODDARD H GIBBS AR

Citation: Fg. Mayall et al., THE FREQUENCY OF P53 IMMUNOSTAINING IN ASBESTOS-ASSOCIATED MESOTHELIOMAS AND NON-ASBESTOS-ASSOCIATED MESOTHELIOMAS, Histopathology, 22(4), 1993, pp. 383-386

Authors: MAYALL FG GODDARD H GIBBS AR

Citation: Fg. Mayall et al., THE DIAGNOSTIC IMPLICATIONS OF VARIABLE CYTOKERATIN EXPRESSION IN MESOTHELIOMAS, Journal of pathology, 170(2), 1993, pp. 165-168